Emergence of a senescent and inflammatory pulmonary CD4 + T cell population prior to lung allograft failure
Science Advances · 2025
DOI: 10.1126/sciadv.adp9052 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, 2025. Verfasst von Sajad Moshkelgosha und 19 weiteren Autor:innen. Beteiligte Einrichtung: Toronto General Hospital Research Institute, University Health Network, Toronto, ON, Canada. Hauptthemen laut MEDLINE: Lung Transplantation, CD4-Positive T-Lymphocytes, Cellular Senescence, Graft Rejection. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Survival after lung transplantation is limited by chronic lung allograft dysfunction (CLAD), an alloimmune fibrotic process leading to death or retransplantation after a median of 6 years. Immunosuppression fails to prevent CLAD, suggesting the existence of drug-resistant alloimmune pathways. We used time-of-flight mass cytometry to identify cells enriched in the bronchoalveolar lavage of patients with subsequent acute lung allograft dysfunction (ALAD), a risk factor for CLAD. We show that CD4 + CD57 + PD1 + T cells emerge in stable patients, conferring risks for ALAD, CLAD, and death. These cells are senescent, secrete inflammatory cytokines, and fall into two oligoclonal subsets with putative cytotoxic and follicular helper functions. Last, they are associated with fibrosis in mouse and human lung allografts, where they localize near airway epithelium and B cells. Together, our findings reveal an inflammatory T cell population that predicts future lung allograft dysfunction and may represent a rational therapeutic target.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Toronto General Hospital Research Institute, University Health Network, Toronto, ON, Canada.
- Sheba Medical Center, Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel.
- Barts Health NHS Trust, London, UK.
- Nouvel Hôpital Civil, Strasbourg, France.
- Department of Thoracic Surgery, Institute of Development, Aging and Cancer, Tohoku University, Sendai, Japan.
- Biostatistics Department, University Health Network, Toronto, ON, Canada.
ORCID-Profile: Sajad Moshkelgosha, Liran Levy, Shahideh Safavi, Sumiha Karunagaran, Gavin Wilson, Benjamin Renaud-Picard, Rashi Ramchandani, Ke Fan Bei, Betty Joe, Qixuan Li, Jonathan Yeung, Shaf Keshavjee, Tereza Martinu, Stephen Juvet
Zitieren
APA
Moshkelgosha, S., Levy, L., Safavi, S., Karunagaran, S., Wilson, G., Renaud-Picard, B., Madu, G., Ramchandani, R., Oliver, J., Watanabe, T., Bei, K. F., Joe, B., Li, Q., Huszti, E., Cheung, M., Hedley, D., Yeung, J., Keshavjee, S., Martinu, T., & Juvet, S. (2025). Emergence of a senescent and inflammatory pulmonary CD4 + T cell population prior to lung allograft failure. Science Advances. https://doi.org/10.1126/sciadv.adp9052
Vancouver
Moshkelgosha S, Levy L, Safavi S, Karunagaran S, Wilson G, Renaud-Picard B, et al. Emergence of a senescent and inflammatory pulmonary CD4 + T cell population prior to lung allograft failure. Science Advances. 2025. doi:10.1126/sciadv.adp9052
BibTeX
@article{Moshkelgosha2025,
author = {Moshkelgosha, Sajad and Levy, Liran and Safavi, Shahideh and Karunagaran, Sumiha and Wilson, Gavin and Renaud-Picard, Benjamin and Madu, Goodness and Ramchandani, Rashi and Oliver, Jillian and Watanabe, Tatsuaki and Bei, Ke Fan and Joe, Betty and Li, Qixuan and Huszti, Ella and Cheung, May and Hedley, David and Yeung, Jonathan and Keshavjee, Shaf and Martinu, Tereza and Juvet, Stephen},
title = {Emergence of a senescent and inflammatory pulmonary CD4 + T cell population prior to lung allograft failure},
journal = {Science Advances},
year = {2025},
doi = {10.1126/sciadv.adp9052}
}
EUVIMED